Alkesh Jani
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 12 | 2021 | 701 | 3.160 |
Why?
| | Cold Ischemia | 7 | 2021 | 30 | 3.060 |
Why?
| | Apoptosis | 14 | 2021 | 2557 | 2.270 |
Why?
| | Kidney | 16 | 2025 | 1472 | 2.160 |
Why?
| | Organ Preservation | 5 | 2018 | 102 | 2.120 |
Why?
| | Hibernation | 6 | 2016 | 75 | 1.780 |
Why?
| | Acute Kidney Injury | 11 | 2021 | 811 | 1.780 |
Why?
| | Kidney Tubules | 5 | 2016 | 117 | 1.470 |
Why?
| | Caspase Inhibitors | 3 | 2018 | 81 | 1.280 |
Why?
| | Sciuridae | 4 | 2016 | 147 | 1.160 |
Why?
| | Caspase 3 | 8 | 2018 | 246 | 1.070 |
Why?
| | Reperfusion Injury | 4 | 2021 | 279 | 1.060 |
Why?
| | Necrosis | 4 | 2021 | 244 | 1.020 |
Why?
| | Delayed Graft Function | 3 | 2018 | 33 | 0.990 |
Why?
| | Rewarming | 2 | 2016 | 20 | 0.960 |
Why?
| | Caspase 1 | 4 | 2021 | 143 | 0.870 |
Why?
| | Autophagy | 4 | 2016 | 282 | 0.850 |
Why?
| | Warm Ischemia | 2 | 2020 | 12 | 0.790 |
Why?
| | Ischemia | 6 | 2020 | 408 | 0.770 |
Why?
| | Organ Preservation Solutions | 2 | 2018 | 46 | 0.670 |
Why?
| | Mice, Inbred C57BL | 18 | 2025 | 5792 | 0.640 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 274 | 0.620 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2016 | 50 | 0.620 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 25 | 0.600 |
Why?
| | Cold Temperature | 3 | 2016 | 177 | 0.580 |
Why?
| | Quinolines | 1 | 2018 | 180 | 0.540 |
Why?
| | Animals | 31 | 2025 | 37011 | 0.510 |
Why?
| | Nephrectomy | 4 | 2018 | 168 | 0.500 |
Why?
| | Thiones | 1 | 2015 | 14 | 0.490 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.490 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 300 | 0.480 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 46 | 0.470 |
Why?
| | Renal Artery | 1 | 2015 | 37 | 0.470 |
Why?
| | Pyrimidinones | 1 | 2015 | 114 | 0.460 |
Why?
| | Mice | 20 | 2025 | 17843 | 0.460 |
Why?
| | Microsurgery | 1 | 2015 | 80 | 0.450 |
Why?
| | Arousal | 2 | 2012 | 162 | 0.450 |
Why?
| | Models, Animal | 4 | 2020 | 387 | 0.440 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 437 | 0.420 |
Why?
| | Renin-Angiotensin System | 1 | 2013 | 84 | 0.410 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4295 | 0.400 |
Why?
| | Creatinine | 4 | 2020 | 501 | 0.370 |
Why?
| | Reperfusion | 1 | 2011 | 40 | 0.370 |
Why?
| | Blood Proteins | 1 | 2012 | 250 | 0.330 |
Why?
| | Adaptation, Physiological | 1 | 2013 | 546 | 0.320 |
Why?
| | Polycystic Kidney Diseases | 2 | 2025 | 76 | 0.300 |
Why?
| | Body Temperature | 3 | 2013 | 221 | 0.270 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 75 | 0.230 |
Why?
| | Cisplatin | 4 | 2015 | 318 | 0.230 |
Why?
| | Male | 20 | 2025 | 67718 | 0.230 |
Why?
| | Tissue Donors | 3 | 2021 | 417 | 0.230 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2004 | 49 | 0.220 |
Why?
| | Interleukin-18 | 3 | 2013 | 237 | 0.210 |
Why?
| | Kidney Failure, Chronic | 2 | 2008 | 565 | 0.200 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2615 | 0.200 |
Why?
| | Thiamine Deficiency | 1 | 2022 | 10 | 0.200 |
Why?
| | Swine | 2 | 2015 | 775 | 0.200 |
Why?
| | Renal Circulation | 3 | 2015 | 58 | 0.190 |
Why?
| | Acidosis, Lactic | 1 | 2022 | 46 | 0.190 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 414 | 0.190 |
Why?
| | Mice, Knockout | 5 | 2025 | 3020 | 0.190 |
Why?
| | Signal Transduction | 5 | 2021 | 5096 | 0.180 |
Why?
| | Seasons | 3 | 2015 | 546 | 0.180 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 87 | 0.170 |
Why?
| | Glomerular Filtration Rate | 2 | 2012 | 746 | 0.160 |
Why?
| | Interleukin-8 | 2 | 2013 | 269 | 0.160 |
Why?
| | Caspases | 3 | 2013 | 247 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2011 | 277 | 0.150 |
Why?
| | Cytokines | 5 | 2015 | 2095 | 0.150 |
Why?
| | Cells, Cultured | 3 | 2016 | 4206 | 0.150 |
Why?
| | Kidney Tubular Necrosis, Acute | 2 | 2011 | 26 | 0.150 |
Why?
| | Graft Rejection | 1 | 2002 | 623 | 0.140 |
Why?
| | Epithelial Cells | 3 | 2014 | 1099 | 0.140 |
Why?
| | Perfusion | 2 | 2011 | 212 | 0.130 |
Why?
| | LLC-PK1 Cells | 1 | 2015 | 18 | 0.120 |
Why?
| | Cytoprotection | 1 | 2015 | 56 | 0.120 |
Why?
| | Alcoholism | 1 | 2022 | 805 | 0.120 |
Why?
| | Transfection | 2 | 2016 | 948 | 0.120 |
Why?
| | AMP Deaminase | 1 | 2015 | 12 | 0.120 |
Why?
| | Biological Assay | 1 | 2016 | 123 | 0.120 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 30 | 0.120 |
Why?
| | Transplants | 1 | 2015 | 36 | 0.120 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 154 | 0.110 |
Why?
| | Species Specificity | 1 | 2016 | 593 | 0.110 |
Why?
| | Phosphorylation | 2 | 2016 | 1762 | 0.110 |
Why?
| | Macrolides | 1 | 2014 | 63 | 0.110 |
Why?
| | Phenanthrenes | 1 | 2014 | 13 | 0.110 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1740 | 0.110 |
Why?
| | Cell Line | 2 | 2018 | 2852 | 0.110 |
Why?
| | Diterpenes | 1 | 2014 | 31 | 0.110 |
Why?
| | RNA Interference | 1 | 2016 | 464 | 0.110 |
Why?
| | Antineoplastic Agents | 3 | 2014 | 2145 | 0.110 |
Why?
| | Physiology, Comparative | 1 | 2013 | 3 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 197 | 0.100 |
Why?
| | Ursidae | 1 | 2012 | 7 | 0.100 |
Why?
| | Acute-Phase Proteins | 1 | 2013 | 67 | 0.100 |
Why?
| | Lipocalins | 1 | 2013 | 37 | 0.100 |
Why?
| | Blotting, Western | 2 | 2012 | 1227 | 0.100 |
Why?
| | Biomarkers | 4 | 2018 | 4172 | 0.100 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.100 |
Why?
| | Nephrology | 1 | 2012 | 61 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2015 | 1092 | 0.090 |
Why?
| | Serum Albumin | 1 | 2012 | 150 | 0.090 |
Why?
| | Thrombosis | 1 | 2015 | 368 | 0.090 |
Why?
| | Raffinose | 1 | 2011 | 24 | 0.090 |
Why?
| | DNA Primers | 1 | 2012 | 514 | 0.090 |
Why?
| | bcl-X Protein | 1 | 2011 | 43 | 0.090 |
Why?
| | Sus scrofa | 1 | 2011 | 52 | 0.090 |
Why?
| | Allopurinol | 1 | 2011 | 64 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2015 | 624 | 0.090 |
Why?
| | Tissue and Organ Harvesting | 1 | 2011 | 71 | 0.080 |
Why?
| | Hemodynamics | 1 | 2015 | 1114 | 0.080 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 433 | 0.080 |
Why?
| | Chemokine CXCL1 | 4 | 2012 | 76 | 0.080 |
Why?
| | Death | 1 | 2011 | 119 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 974 | 0.080 |
Why?
| | Interleukins | 1 | 2011 | 251 | 0.080 |
Why?
| | Macrophages | 3 | 2013 | 1548 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 646 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 354 | 0.080 |
Why?
| | Adenosine | 1 | 2011 | 227 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 533 | 0.080 |
Why?
| | Glutathione | 1 | 2011 | 358 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 770 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2012 | 488 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2015 | 10821 | 0.070 |
Why?
| | Cyst Fluid | 1 | 2008 | 25 | 0.070 |
Why?
| | Receptors, Interleukin-8B | 1 | 2008 | 26 | 0.070 |
Why?
| | Kidney Glomerulus | 2 | 2011 | 114 | 0.070 |
Why?
| | Cysts | 1 | 2008 | 111 | 0.070 |
Why?
| | Kidney Diseases | 2 | 2008 | 407 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 379 | 0.070 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 616 | 0.060 |
Why?
| | Postoperative Complications | 2 | 2015 | 2641 | 0.060 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Proteomics | 1 | 2012 | 1113 | 0.060 |
Why?
| | Liver Transplantation | 1 | 2013 | 872 | 0.060 |
Why?
| | Thermosensing | 1 | 2004 | 11 | 0.060 |
Why?
| | Caspase 2 | 1 | 2004 | 13 | 0.060 |
Why?
| | Kidney Cortex | 1 | 2004 | 26 | 0.060 |
Why?
| | Liver Diseases | 1 | 2008 | 313 | 0.060 |
Why?
| | Caspase 8 | 1 | 2004 | 49 | 0.060 |
Why?
| | DNA Fragmentation | 1 | 2004 | 42 | 0.060 |
Why?
| | Caspase 9 | 1 | 2004 | 57 | 0.060 |
Why?
| | Kidney Function Tests | 2 | 2015 | 158 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 124 | 0.060 |
Why?
| | Microvilli | 1 | 2004 | 79 | 0.060 |
Why?
| | Calpain | 1 | 2004 | 59 | 0.060 |
Why?
| | Liver | 2 | 2015 | 1940 | 0.050 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 260 | 0.050 |
Why?
| | Immunoblotting | 1 | 2004 | 307 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 283 | 0.050 |
Why?
| | Scleroderma, Systemic | 1 | 2004 | 122 | 0.050 |
Why?
| | Acute Disease | 2 | 2008 | 1008 | 0.050 |
Why?
| | Humans | 13 | 2022 | 137514 | 0.050 |
Why?
| | Pancreas Transplantation | 1 | 2003 | 75 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2003 | 72 | 0.050 |
Why?
| | Thiamine | 1 | 2022 | 13 | 0.050 |
Why?
| | Sirolimus | 1 | 2003 | 275 | 0.040 |
Why?
| | Temperature | 1 | 2004 | 680 | 0.040 |
Why?
| | Food | 1 | 2022 | 159 | 0.040 |
Why?
| | Neutrophil Infiltration | 2 | 2013 | 107 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2666 | 0.040 |
Why?
| | Interleukin-1beta | 2 | 2013 | 373 | 0.040 |
Why?
| | Reference Values | 1 | 2002 | 821 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2482 | 0.040 |
Why?
| | Insulin | 1 | 2011 | 2398 | 0.040 |
Why?
| | TRPP Cation Channels | 2 | 2011 | 84 | 0.040 |
Why?
| | Risk Factors | 2 | 2013 | 10356 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 849 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 6817 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2011 | 1185 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 163 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2015 | 135 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 116 | 0.030 |
Why?
| | Homozygote | 1 | 2015 | 203 | 0.030 |
Why?
| | Peroxidase | 1 | 2015 | 176 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 170 | 0.030 |
Why?
| | Tumor Burden | 1 | 2015 | 311 | 0.030 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2014 | 29 | 0.030 |
Why?
| | Endothelial Cells | 2 | 2011 | 780 | 0.030 |
Why?
| | Epoxy Compounds | 1 | 2014 | 33 | 0.030 |
Why?
| | Interleukin-1alpha | 1 | 2013 | 58 | 0.030 |
Why?
| | Uremia | 1 | 2012 | 16 | 0.030 |
Why?
| | Adult | 5 | 2013 | 37821 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3420 | 0.030 |
Why?
| | Obesity, Abdominal | 1 | 2013 | 48 | 0.020 |
Why?
| | Lipocalin-2 | 1 | 2013 | 79 | 0.020 |
Why?
| | Kidney Tubules, Proximal | 1 | 2013 | 128 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2013 | 205 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 151 | 0.020 |
Why?
| | Clodronic Acid | 1 | 2012 | 17 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 322 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 445 | 0.020 |
Why?
| | Thromboembolism | 1 | 2012 | 119 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2012 | 65 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 511 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 117 | 0.020 |
Why?
| | Interleukin-33 | 1 | 2011 | 49 | 0.020 |
Why?
| | Beclin-1 | 1 | 2011 | 11 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1059 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 152 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 986 | 0.020 |
Why?
| | Middle Aged | 4 | 2013 | 33355 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2013 | 366 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2011 | 153 | 0.020 |
Why?
| | Triglycerides | 1 | 2013 | 525 | 0.020 |
Why?
| | Female | 4 | 2013 | 73162 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 188 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 386 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 327 | 0.020 |
Why?
| | Glucose | 1 | 2015 | 1018 | 0.020 |
Why?
| | Osteoporosis | 1 | 2012 | 242 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 197 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1271 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 53 | 0.020 |
Why?
| | Colorado | 2 | 2013 | 4521 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2008 | 62 | 0.020 |
Why?
| | Chemokine CXCL5 | 1 | 2008 | 11 | 0.020 |
Why?
| | Cell Shape | 1 | 2008 | 58 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1950 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 321 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2012 | 963 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1618 | 0.020 |
Why?
| | Chemokines | 1 | 2008 | 229 | 0.020 |
Why?
| | Estradiol | 1 | 2011 | 513 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 227 | 0.020 |
Why?
| | Cell Polarity | 1 | 2008 | 141 | 0.020 |
Why?
| | Incidence | 1 | 2013 | 2792 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1776 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2008 | 475 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3292 | 0.010 |
Why?
| | Insulin Resistance | 1 | 2013 | 1198 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2420 | 0.010 |
Why?
| | Cadaver | 1 | 2004 | 319 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1255 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2182 | 0.010 |
Why?
| | Hospitals, University | 1 | 2003 | 181 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 1701 | 0.010 |
Why?
| | Living Donors | 1 | 2004 | 295 | 0.010 |
Why?
| | Rats | 1 | 2011 | 5676 | 0.010 |
Why?
| | Cyclosporine | 1 | 2003 | 268 | 0.010 |
Why?
| | Graft Survival | 1 | 2004 | 540 | 0.010 |
Why?
| | Tacrolimus | 1 | 2003 | 199 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1320 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1458 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7593 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 1060 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2193 | 0.010 |
Why?
| | Skin | 1 | 2004 | 751 | 0.010 |
Why?
| | Aged | 2 | 2013 | 23798 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2066 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2013 | 2521 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2003 | 891 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 13243 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2004 | 15628 | 0.010 |
Why?
| | Adolescent | 1 | 2013 | 21555 | 0.010 |
Why?
| | United States | 1 | 2004 | 14696 | 0.000 |
Why?
|
|
Jani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|